位置:首页 > 蛋白库 > DAPLE_XENLA
DAPLE_XENLA
ID   DAPLE_XENLA             Reviewed;        2058 AA.
AC   P85120;
DT   17-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   17-APR-2007, sequence version 1.
DT   03-AUG-2022, entry version 48.
DE   RecName: Full=Protein Daple {ECO:0000303|PubMed:30948426};
DE            Short=xDaple {ECO:0000303|PubMed:30948426};
DE   AltName: Full=Coiled-coil domain-containing protein 88C;
DE   AltName: Full=Dvl-associating protein with a high frequency of leucine residues-like;
DE            Short=xDal;
GN   Name=ccdc88c; Synonyms=dal;
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX   NCBI_TaxID=8355;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH DVL2, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Embryo {ECO:0000269|PubMed:16026968};
RX   PubMed=16026968; DOI=10.1016/j.mod.2005.05.003;
RA   Kobayashi H., Michiue T., Yukita A., Danno H., Sakurai K., Fukui A.,
RA   Kikuchi A., Asashima M.;
RT   "Novel Daple-like protein positively regulates both the Wnt/beta-catenin
RT   pathway and the Wnt/JNK pathway in Xenopus.";
RL   Mech. Dev. 122:1138-1153(2005).
RN   [2]
RP   FUNCTION, DISRUPTION PHENOTYPE, GBA MOTIFS, AND MUTAGENESIS OF PHE-1662;
RP   PHE-1689 AND 2055-TYR--VAL-2058.
RX   PubMed=30948426; DOI=10.1083/jcb.201811174;
RA   Marivin A., Morozova V., Walawalkar I., Leyme A., Kretov D.A.,
RA   Cifuentes D., Dominguez I., Garcia-Marcos M.;
RT   "GPCR-independent activation of G proteins promotes apical cell
RT   constriction in vivo.";
RL   J. Cell Biol. 218:1743-1763(2019).
CC   -!- FUNCTION: Positive regulator of Wnt signaling, acting synergistically
CC       with dvl2/dsh (PubMed:16026968). Functions upstream of ctnnb1/beta-
CC       catenin in the canonical Wnt pathway, and also activates jnk in the
CC       Wnt/planar cell polarity (PCP) pathway (PubMed:16026968). Acts as a
CC       non-receptor guanine nucleotide exchange factor which binds to and
CC       activates guanine nucleotide-binding protein G(i) alpha subunits
CC       (PubMed:30948426). This promotes apical cell constriction and
CC       subsequent bending of the neural plate during neurulation via arhgef18
CC       (PubMed:30948426). {ECO:0000269|PubMed:16026968,
CC       ECO:0000269|PubMed:30948426}.
CC   -!- SUBUNIT: Interacts with dvl2/dsh via the PDZ-binding motif.
CC       {ECO:0000269|PubMed:16026968}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9P219}. Cell
CC       junction {ECO:0000269|PubMed:30948426}. Note=Enriched at apical cell
CC       junctions. {ECO:0000269|PubMed:30948426}.
CC   -!- TISSUE SPECIFICITY: Expressed weakly in gastrulae, with slightly
CC       stronger expression in the dorsal region. In neurulae, expressed in the
CC       neural plate with strong expression in the presumptive mesencephalic
CC       region. At the tailbud stage, expressed in somatic cells and in part of
CC       the tail. Also strongly expressed in regions of the head including eye
CC       vesicles, otic vesicles, olfactory placode and the pharyngeal cavity.
CC       {ECO:0000269|PubMed:16026968}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in all developmental stages, with a
CC       gradual increase in expression from the 2-day tadpole stage onward.
CC       {ECO:0000269|PubMed:16026968}.
CC   -!- DOMAIN: The GBA (G-alpha binding and activating) motif mediates binding
CC       to the alpha subunits of guanine nucleotide-binding proteins (G
CC       proteins) (PubMed:30948426). Both motifs are required for binding and
CC       activation of alpha subunits (PubMed:30948426).
CC       {ECO:0000269|PubMed:30948426}.
CC   -!- DOMAIN: The PDZ domain is required for localization to apical
CC       junctions. {ECO:0000269|PubMed:30948426}.
CC   -!- DISRUPTION PHENOTYPE: Morpholino knockdown does not affect embryo
CC       morphology up to gastrulation but causes a delay in the closure of the
CC       neural tube (PubMed:30948426). After the neural tube closes, embryos
CC       display mild axis curvature and head defects at later stages and
CC       malformations are also evident in the embryonic brain which forms a
CC       closed structure but displays an enlargement of the ventricles
CC       (PubMed:30948426). Embryos show impaired apical constriction of
CC       neuroepithelial cells during neurulation (PubMed:30948426).
CC       {ECO:0000269|PubMed:30948426}.
CC   -!- SIMILARITY: Belongs to the CCDC88 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   AlphaFoldDB; P85120; -.
DR   SMR; P85120; -.
DR   MaxQB; P85120; -.
DR   PRIDE; P85120; -.
DR   Proteomes; UP000186698; Genome assembly.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IMP:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0001965; F:G-protein alpha-subunit binding; ISS:UniProtKB.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:UniProtKB.
DR   GO; GO:0030165; F:PDZ domain binding; ISS:UniProtKB.
DR   GO; GO:0003383; P:apical constriction; IMP:UniProtKB.
DR   GO; GO:0030705; P:cytoskeleton-dependent intracellular transport; IEA:InterPro.
DR   GO; GO:0009950; P:dorsal/ventral axis specification; IMP:UniProtKB.
DR   GO; GO:0001736; P:establishment of planar polarity; IMP:UniProtKB.
DR   GO; GO:0001841; P:neural tube formation; IMP:UniProtKB.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IGI:UniProtKB.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IMP:UniProtKB.
DR   GO; GO:2000096; P:positive regulation of Wnt signaling pathway, planar cell polarity pathway; IMP:UniProtKB.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IDA:UniProtKB.
DR   GO; GO:0031098; P:stress-activated protein kinase signaling cascade; ISS:UniProtKB.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR027719; Daple.
DR   InterPro; IPR043936; HOOK_N.
DR   PANTHER; PTHR18947:SF31; PTHR18947:SF31; 1.
DR   Pfam; PF19047; HOOK_N; 1.
DR   PROSITE; PS50021; CH; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Coiled coil; Cytoplasm; Guanine-nucleotide releasing factor;
KW   Reference proteome; Wnt signaling pathway.
FT   CHAIN           1..2058
FT                   /note="Protein Daple"
FT                   /id="PRO_0000284727"
FT   DOMAIN          11..131
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   REGION          1406..1444
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1480..1592
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1617..1655
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1696..1724
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1831..1857
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1940..1959
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1988..2051
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          195..221
FT                   /evidence="ECO:0000255"
FT   COILED          247..428
FT                   /evidence="ECO:0000255"
FT   COILED          455..1016
FT                   /evidence="ECO:0000255"
FT   COILED          1043..1082
FT                   /evidence="ECO:0000255"
FT   COILED          1108..1388
FT                   /evidence="ECO:0000255"
FT   MOTIF           1653..1675
FT                   /note="GBA 1"
FT                   /evidence="ECO:0000269|PubMed:30948426"
FT   MOTIF           1676..1697
FT                   /note="GBA 2"
FT                   /evidence="ECO:0000269|PubMed:30948426"
FT   MOTIF           2055..2058
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1419..1444
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1505..1520
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1547..1582
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1696..1721
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1994..2019
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MUTAGEN         1662
FT                   /note="F->A: Partial reduction in activation of rat Gnai3.
FT                   Abolishes Gnai3 binding and activation, abolishes promotion
FT                   of apical cell constriction and fails to rescue morpholino-
FT                   induced neural plate bending defects but does not affect
FT                   enrichment at apical cell junctions; when associated with
FT                   A-1689."
FT                   /evidence="ECO:0000269|PubMed:30948426"
FT   MUTAGEN         1689
FT                   /note="F->A: Partial reduction in activation of rat Gnai3.
FT                   Abolishes Gnai3 binding and activation, abolishes promotion
FT                   of apical cell constriction and fails to rescue morpholino-
FT                   induced neural plate bending defects but does not affect
FT                   enrichment at apical cell junctions; when associated with
FT                   A-1662."
FT                   /evidence="ECO:0000269|PubMed:30948426"
FT   MUTAGEN         2055..2058
FT                   /note="Missing: Failure to localize to apical cell
FT                   junctions and to induce apical cell constriction. Failure
FT                   to rescue morpholino-induced neural plate bending defects."
FT                   /evidence="ECO:0000269|PubMed:30948426"
SQ   SEQUENCE   2058 AA;  236339 MW;  C3DA456113A0AD80 CRC64;
     MDTTISQQMD HFLESPLVTW VKTFGPCGNE NESKLAMYME LVDGVFLNKI MVQIDPRPSN
     QRVNKHVNND VNRRVQNLTI LVRHIKAYYQ EVLQQLIVMN LPNVLLISKD PLTDKSMEEL
     KKILLLMLGC AVQCERKEEY IERIKQLDIE TQAGIVSHIQ EVTHNQENVF DLQWLELSDM
     APEELDSLSR NMALHLKRLI DERDECKEVI VDLTQERDYL QFQNHPSPVK SSSPDTSANM
     VSHLSSEDKK HLAVELAESK AKLRRIRQEL EEKSELLLDT KHEVERLNLE LQKIKQENFQ
     LASEARTART YRDEIDSLKE RASKVDRLEN ELARCKEKLH DVDFYKARMD ELREDNMILI
     ETKSMLEEQL AAARTRTDKL HELEKENLQL KSKIHDLELD RYSDKNRIEE LLEENMVLEI
     AQKQSMNESA QLGWELDQLS KSTDLSDARK SFVFELNETT SSKILKLEKE NQSLQNIIQD
     LREASLTLEE GNLKGQEWEK ENQQLSKKIE NLNQQIERER QSSLDLESLS EDLLKEKDQL
     SQALENIKSQ KERQIKELEQ ENKHLIQTLE AVRQRSQVST EARVKDIEME NRILHETIKD
     TSSKMNELEY EKKQLQKAFD QSKEQVEKLD KMEKEVHRLE KQNEILTKKV TSIKIVEEKM
     QGLEKENEVL EGENIVLKKS LDTLQNVTIK LEVLESENKQ LDEENLELRR AVEAMRFSCA
     KSTQIERENN ELQKEKEELQ KNVELLKALG KKSERLEVSY QGLNDENWRL QQMLDTGNKK
     INDLEKELHD TEKENKDLQR TLEEMKICNK RLERMEEENK AKEQEMVQLE KDNKILQKES
     KRLWQQVELK DAILDDNTVK LADLEKENRA LEKEISKLRD LSTKTRDLER ENKDLLQQMT
     VDKRTLATLR EDLVLEKLKT QQMSSELDKL SLELEKIGLN KESMLQDENS NAEKKYKLLE
     NKIESTLKTT LAVKENKIVA LEMKIEETSS LNQQLQNELN SIKKDIIASK ENLRGAAHNS
     YTQLSSKQDC NSQINGQRET TVELLKFKDR TIELERNNAA LQAEKKLFRE QLQHLESHNL
     NLSSQMGTLQ KQVTFLQEHN TALQTQTANL QVENATATSQ VASLKSQISQ FQNQLSARES
     ENEILQQQKE HLRVTHESLL QDHEQLGSLY ERQSAEYEGM ISQHSSLKSQ YKSLEQAHRS
     LEESYSTLIK HKKELEDLDA VLKKEQDVLQ QERRKNFVAM EENQKLKTDL ERLNFLHGEL
     QTEYSSLHKH TKEVKTSLNN AQMELNRWQA RFDELKEQHQ TMDISLTKLD NHCELLTRLK
     SNLEEENHHL LSQIQMLSQQ NQMLLEQSME TKEQYHEEQK QYIDKLHDLR RQKEKLEEKI
     MDQYKFYDPT PKKKSHWSGA KAIAKLIKPK KEPSRESVKS PTDVQSKTMD NAEMAASPSS
     MRPLRLQQES LDNSSLGSDE KGSPKVLASK VLVEVAQRQH RMSYHGSSSE QTDGPEHLSR
     SRRMESGSRA FSTSTIHLTA PAHNAKVPHL SRPKGYNSDD NQSDQLHEAE SNAGSSRVPW
     TSSLEVSRSA SNSSSPLTLK GRPESVSSED MIPTKDIATL SRESNLYHPN AVMLGATKNR
     ESPVNRNSLH LYDYPEKKNS SRTPTRPRPG SPGSEMVTLE EFLQESSRQS PPSRRHSLND
     SELITLHQFL FEAETLHPSS QSPSPTLHLK DPSQTAVPKS LPSAENCEWR KRADRASRRA
     ASLYIPRDMV TNRDDMLGDL FKKTEDPPDI RSPMSELIFK DAAQMPTSYV SPTVKVTGNT
     TKPGQYVKPH PRQLDAPLNV TSSLLHQANV YSATSSSQSP EPQALSPHGA MGSRGNSLSR
     AFSLASADLL KENGPEVVMQ EKSDVETPVG KDFGRYMIRS STPLGSQSSL REKPQSARMQ
     HMLRGDDRQY RSLDSRRLSL ALPKEETTPP QPAPSASSLQ QHYTLGHGAI RGKPKLLSRS
     GEVALVSPVR PISSIPELET TQGLASAGPG KSRSTSPDCS PAPVCEEEPN KSETLKSTPA
     SPDPSADPQT VWYEYGCV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024